Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
They should match the specific batch purchased, not generic product testing
The COA-before-purchase policy is why I stay
After 15 years of compounding peptides for patientsBPC-157 for inflammatory bowel disease, CJC-1295 for growth hormone deficiencythe FDA had just added his two highest-volume compounds to their Category 2 list
The Category 2 Bombshell In October 2023, the FDA fundamentally altered the peptide landscape by designating 17 peptides as Category 2 substancesbanned from all compounding regardless of prescription validity or patient need
Several deaths and numerous hospitalizations link to contaminated peptides, though published data remains limited. The Fundamental Tension Current peptide regulation embodies a fundamental conflict between precaution and access
US$ 21.27
US$ 26.34
US$ 21.84
US$ 28.21
US$ 28.64
US$ 28.64
